Holocene Advisors’s Centessa Pharmaceuticals CNTA Stock Holding History

Holocene Advisors’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-160,942	Closed	-$6.39M	–	851
2026 Q1	$6.39M	Buy	160,942 +59,345	+58%	+$1.52M	0.02%	362
2025 Q4	$2.54M	Buy	+101,597	New	+$2.57M	0.01%	468
2025 Q2	–	Sell	-2,255,679	Closed	-$32.4M	–	774
2025 Q1	$32.4M	Buy	+2,255,679	New	+$36.9M	0.09%	203

Holocene Advisors's CNTA Position: Q2 2026 in Review

Holocene Advisors sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 160,942 shares — an estimated $6.39M sold.

Holocene Advisors first reported a position in CNTA in Q1 2025 and held it in 3 quarters. The position peaked at $32.4M in Q1 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Holocene Advisors reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Holocene Advisors sold 160,942 Centessa Pharmaceuticals shares in Q2 2026, an estimated $6.39M.
Holocene Advisors first reported a position in Centessa Pharmaceuticals in Q1 2025 and held it in 3 quarters.
Holocene Advisors's Centessa Pharmaceuticals position peaked at $32.4M in Q1 2025.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.